Publikationen 2012

Albers P.
[In Process Citation].
Aktuelle Urol. 2012 Dec;43(6):369-70. doi: 10.1055/s-0032-1332776. Epub 2012 Dec 19. German.
PubMed PMID: 23254346.

Albers P.
[Retroperitoneal residual tumor resection after chemotherapy of malignant testicular cancers].
Aktuelle Urol. 2012 May;43(3):197-206. doi: 10.1055/s-0029-1233516. Epub 2012 May 25. German.
PubMed PMID: 22639031.

Albers P.
[Retroperitoneal lymphadenectomy - pro robotic].
Urologe A. 2012 May;51(5):687-91. doi: 10.1007/s00120-012-2888-4. German.
PubMed PMID: 22534764.

Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, Horwich A, Laguna MP; European Association of Urology.
[EAU guidelines on testicular cancer: 2011 update. European Association of Urology].
Actas Urol Esp. 2012 Mar;36(3):127-45. doi: 10.1016/j.acuro.2011.06.017. Epub 2011 Dec 20. Spanish.
PubMed PMID: 22188753.

Arsov C, Blondin D, Rabenalt R, Antoch G, Albers P, Quentin M.
[Standardised scoring of a multi-parametric 3-T MRI for a targeted MRI-guided prostate biopsy].
Urologe A. 2012 Jun;51(6):848-56. doi: 10.1007/s00120-012-2825-6. German.
PubMed PMID: 22476739.

Arsov C, Quentin M, Rabenalt R, Antoch G, Albers P, Blondin D.
Repeat transrectal ultrasound biopsies with additional targeted cores according to results of functional prostate MRI detects high-risk prostate cancer in patients with previous negative biopsy and increased PSA - a pilot study.
Anticancer Res. 2012 Mar;32(3):1087-92.
PubMed PMID: 22399637.

Arsov C, Winter C, Rabenalt R, Albers P.
Current second-line treatment options for patients with castration resistant prostate cancer (CRPC) resistant to docetaxel.
Urol Oncol. 2012 Nov-Dec;30(6):762-71. doi: 10.1016/j.urolonc.2010.02.001. Epub 2010 Sep 29.
PubMed PMID: 20884252.

Barski D, Richter M, Winter C, Arsov C, de Geeter P, Rabenalt R, Albers P.
Holmium laser ablation of the prostate (HoLAP): intermediate-term results of 144 patients.
World J Urol. 2012 Jul 11. [Epub ahead of print]
PubMed PMID: 22782618.

Beyer J, Albers P, Altena R, Aparicio J, Bokemeyer C, Busch J, Cathomas R, Cavallin-Stahl E, Clarke NW, Claßen J, Cohn-Cedermark G, Dahl AA, Daugaard G, De Giorgi U, De Santis M, De Wit M, De Wit R, Dieckmann KP, Fenner M, Fizazi K, Flechon A, Fossa SD, Germá Lluch JR, Gietema JA, Gillessen S, Giwercman A, Hartmann JT, Heidenreich A, Hentrich M, Honecker F, Horwich A, Huddart RA, Kliesch S, Kollmannsberger C, Krege S, Laguna MP, Looijenga LH, Lorch A, Lotz JP, Mayer F, Necchi A, Nicolai N, Nuver J, Oechsle K, Oldenburg J, Oosterhuis JW, Powles T, Rajpert-De Meyts E, Rick O, Rosti G, Salvioni R, Schrader M, Schweyer S, Sedlmayer F, Sohaib A, Souchon R, Tandstad T, Winter C, Wittekind C.
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.
Ann Oncol. 2012 Nov 14. [Epub ahead of print]
PubMed PMID: 23152360.

Bramann EL, Willenberg HS, Hildebrandt B, Müller-Mattheis V, Schott M, Scherbaum WA, Haase M.
Griseofulvin Inhibits the Growth of Adrenocortical Cancer Cells In Vitro.
Horm Metab Res. 2012 Oct 30. [Epub ahead of print]
PubMed PMID: 23111828.

Calabrò F, Albers P, Bokemeyer C, Martin C, Einhorn LH, Horwich A, Krege S, Schmoll HJ, Sternberg CN, Daugaard G.
The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature.
Eur Urol. 2012 Jun;61(6):1212-21. doi: 10.1016/j.eururo.2012.03.038. Epub 2012 Mar 24. Review.
PubMed PMID: 22464311.

Cash H, Slowinski T, Buechler A, Grimm A, Friedersdorff F, Schmidt D, Miller K, Giessing M, Fuller TF.
Impact of surgeon experience on complication rates and functional outcomes of 484 deceased donor renal transplants: a single-centre retrospective study.
BJU Int. 2012 Oct;110(8 Pt B):E368-73. doi: 10.1111/j.1464-410X.2012.011024.x. Epub 2012 Mar 9.
PubMed PMID: 22404898.

Chaykovska L, Deger S, Roigas J, Lenz A, Lioudmer P, Kothmann LT, Friedersdorff F, Müller D, Kasper A, Giessing M, Magheli A, Kempkensteffen C, Lingnau A, Fuller TF.
Long-term outcomes of living donor kidney transplants in pediatric recipients following laparoscopic vs. open donor nephrectomy.
Pediatr Transplant. 2012 Dec;16(8):894-900. doi: 10.1111/petr.12008.
PubMed PMID: 23131058.

Daneshmand S, Albers P, Fosså SD, Heidenreich A, Kollmannsberger C, Krege S, Nichols C, Oldenburg J, Wood L.
Contemporary management of postchemotherapy testis cancer.
Eur Urol. 2012 Nov;62(5):867-76. doi: 10.1016/j.eururo.2012.08.014. Epub 2012 Aug 20.
PubMed PMID: 22938868.

de Wit R, Daugaard G, Albers P, White JD, Germa Lluch JR.
Design of testis cancer trials: who knows best?
J Clin Oncol. 2012 Sep 1;30(25):3145-6; author reply 3146-7. doi: 10.1200/JCO.2012.42.2584. Epub 2012 Jul 23.
PubMed PMID: 22826279.

de Wit R, Skoneczna I, Daugaard G, De Santis M, Garin A, Aass N, Witjes AJ, Albers P, White JD, Germa-Lluch JR, Marreaud S, Collette L.
Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983.
J Clin Oncol. 2012 Mar 10;30(8):792-9. doi: 10.1200/JCO.2011.37.0171. Epub 2012 Jan 23.PubMed PMID: 22271474; PubMed Central PMCID: PMC3295568.

Desmarais JA, Hoffmann MJ, Bingham G, Gagou ME, Meuth M, Andrews PW.
Human embryonic stem cells fail to activate CHK1 and commit to apoptosis in response to DNA replication stress.
Stem Cells. 2012 Jul;30(7):1385-93. doi: 10.1002/stem.1117.
PubMed PMID: 22553144

Fei DL, Sanchez-Mejias A, Wang Z, Flaveny C, Long J, Singh S, Rodriguez-Blanco J, Tokhunts R, Giambelli C, Briegel KJ, Schulz WA, Gandolfi AJ, Karagas M, Zimmers TA, Jorda M, Bejarano P, Capobianco AJ, Robbins DJ.
Hedgehog signalling regulates bladder cancer growth and tumorigenicity.
Cancer Res. 2012 Sep 1;72(17):4449-58. Epub 2012 Jul 19.
PubMed PMID: 22815529.

Friedersdorff F, Roller C, Klein G, Werthemann P, Cash H, Budde K, Slowinski T, Kempkensteffen C, Busch J, Fuller TF, Giessing M.
Outcome of expanded criteria donor kidneys that were transplanted at other Eurotransplant centers after being rejected by our institution.
World J Urol. 2012 Aug 18. [Epub ahead of print]
PubMed PMID: 22903774.

Giessing M.
Living donor nephrectomy--quantifying the risk for the donor.
Transplant Proc. 2012 Jul-Aug;44(6):1786-9. doi: 10.1016/j.transproceed.2012.06.006. Review.
PubMed PMID: 22841273.

Giessing M.
Donors with malignancies-risk or chance?
Transplant Proc. 2012 Jul-Aug;44(6):1782-5. doi: 10.1016/j.transproceed.2012.06.005. Review.
PubMed PMID: 22841272.

Giessing M.
Urological knowledge before and after transplantation is of central importance, as donors and recipients are getting older and as kidney recipients may develop urological problems after transplantation. Preface.
Transplant Proc. 2012 Jul-Aug;44(6):1772. doi: 10.1016/j.transproceed.2012.06.007.
PubMed PMID: 22841269.

Goering W, Kloth M, Schulz WA.
DNA methylation changes in prostate cancer.
Methods Mol Biol. 2012;863:47-66. doi: 10.1007/978-1-61779-612-8_4. Review.
PubMed PMID: 22359287.

Hatina J, Schulz WA.
Stem cells in the biology of normal urothelium and urothelial carcinoma.
Neoplasma. 2012;59(6):728-36. doi: 10.4149/neo_2012_089. Review.
PubMed PMID: 22862174.

Heidenreich A, Scholz HJ, Rogenhofer S, Arsov C, Retz M, Müller SC, Albers P, Gschwend J, Wirth M, Steiner U, Miller K, Heinrich E, Trojan L, Volkmer B, Honecker F, Bokemeyer C, Keck B, Otremba B, Ecstein-Fraisse E, Pfister D.
Cabazitaxel Plus Prednisone for Metastatic Castration-resistant Prostate Cancer Progressing After Docetaxel: Results from the German Compassionate-use Programme.
Eur Urol. 2012 Sep 3. doi:pii: S0302-2838(12)01011-1. 10.1016/j.eururo.2012.08.058. [Epub ahead of print]
PubMed PMID: 23116658.

Kälble T, Hofmann I, Thüroff JW, Stein R, Hautmann R, Riedmiller H, Vergho D, Hertle L, Wülfing C, Truß M, Roth S, von Rundstedt FC, Albers P, Gschwend J, Herkommer K, Humke U, Spahn M, Bader P, Steffens J, Harzmann R, Stief CG, Karl A, Müller SC, Waldner M, Noldus J, Kleinschmidt K, Alken P, Kopper B, Fisch M, Lampel A, Stenzel A, Fichtner J, Flath B, Rübben H, Juenemann KP, Hautmann S, Knipper A, Leusmann D, Strohmaier W, Thon WF, Miller S, Weingärtner K, Schilling A, Piechota H, Becht JE, Schwaibold H, Bub P, Conrad S, Wenderoth U, Merkle W, Rösch W, Otto T, Ulshöfer B, Westenfelder M.
[Secondary malignancies in urinary diversions].
Urologe A. 2012 Apr;51(4):500, 502-6. doi: 10.1007/s00120-012-2815-8. German.
PubMed PMID: 22476801.

Kloth M, Goering W, Ribarska T, Arsov C, Sorensen KD, Schulz WA.
The SNP rs6441224 influences transcriptional activity and prognostically relevant hypermethylation of RARRES1 in prostate cancer.
Int J Cancer. 2012 Sep 15;131(6):E897-904. doi: 10.1002/ijc.27628. Epub 2012 May 30.
PubMed PMID: 22573467.

Koch A, Hatina J, Rieder H, Seifert HH, Huckenbeck W, Jankowiak F, Florl AR, Stoehr R, Schulz WA.
Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.
Cell Oncol (Dordr). 2012 Aug;35(4):243-57. doi: 10.1007/s13402-012-0082-8. Epub 2012 Jun 6.
PubMed PMID: 22669776.

Liefeldt L, Klüner C, Glander P, Giessing M, Budde K, Taupitz M, Rogalla P, Kroencke TJ.
Non-invasive imaging of living kidney donors: intraindividual comparison of multislice computed tomography angiography with magnetic resonance angiography.
Clin Transplant. 2012 Jul-Aug;26(4):E412-7. doi: 10.1111/j.1399-0012.2012.01680.x.
PubMed PMID: 22882696.

Lorch A, Kleinhans A, Kramar A, Kollmannsberger CK, Hartmann JT, Bokemeyer C, Rick O, Beyer J.
Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.
J Clin Oncol. 2012 Mar 10;30(8):800-5. doi: 10.1200/JCO.2011.38.6391. Epub 2012 Jan 30.
PubMed PMID: 22291076.

Massard C, Kramar A, Beyer J, Hartmann JT, Lorch A, Pico JL, Rosti G, Droz JP, Fizazi K.
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.
Ann Oncol. 2013 Feb;24(2):322-8. doi: 10.1093/annonc/mds504. Epub 2012 Oct 26.
PubMed PMID: 23104726.

Mehralivand S, Giessing M, Fornara P, Engehausen D, Heynemann H, Wunderlich H, Dreikorn K, Thüroff JW, Stein R.
[19th annual conference of the working group on kidney transplantation of the academy of german urologists : mainz, 10-12 november 2011].
Urologe A. 2012 Apr;51(4):550-4. doi: 10.1007/s00120-012-2848-z. German.
PubMed PMID: 22437445.

Niegisch G, Albers P, Rabenalt R.
[Robot-assisted radical cystectomy: do we actually need a robot?].
Urologe A. 2012 Mar;51(3):319-24. doi: 10.1007/s00120-011-2787-0. Review. German.
PubMed PMID: 22278166.

Niegisch G, Knievel J, Koch A, Hader C, Fischer U, Albers P, Schulz WA.
Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Urol Oncol. 2012 Aug 31. [Epub ahead of print]
PubMed PMID: 22944197.

Niegisch G, Lorch A, Albers P.
[Chemotherapy for urothelial cancer of the bladder--update 2012].
Aktuelle Urol. 2012 Dec;43(6):412-9. doi: 10.1055/s-0032-1327699. Epub 2012 Nov 29. German.
PubMed PMID: 23196781.

Powles T, Albers P.
Management of favorable-risk patients with metastatic renal cell carcinoma: when to start and when to stop targeted therapy.
Clin Genitourin Cancer. 2012 Dec;10(4):213-8. doi: 10.1016/j.clgc.2012.06.002. Epub 2012 Aug 30.
PubMed PMID: 22939100.

Quentin M, Arsov C, Röhlen S, Klasen J, Antoch G, Albers P, Blondin D.
Inter-reader agreement of multi-parametric MR imaging for the detection of prostate cancer: evaluation of a scoring system.
Rofo. 2012 Oct;184(10):925-9. Epub 2012 Jun 28.
PubMed PMID: 22744328.

Quentin M, Blondin D, Klasen J, Lanzman RS, Miese FR, Arsov C, Albers P, Antoch G, Wittsack HJ.
Comparison of different mathematical models of diffusion-weighted prostate MR imaging.
Magn Reson Imaging. 2012 Dec;30(10):1468-74. doi: 10.1016/j.mri.2012.04.025. Epub 2012 Jul 20.
PubMed PMID: 22819178.

Quentin M, Blondin D, Klasen J, Schek J, Buchbender C, Miese FR, Antoch G, Barski D, Albers P, Arsov C.
Evaluation of a structured report of functional prostate magnetic resonance imaging in patients with suspicion for prostate cancer or under active surveillance.
Urol Int. 2012;89(1):25-9. doi: 10.1159/000338808. Epub 2012 Jun 7.
PubMed PMID: 22677880.

Ribarska T, Bastian KM, Koch A, Schulz WA.
Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.
Asian J Androl. 2012 May;14(3):436-50. doi: 10.1038/aja.2011.160. Epub 2012 Feb 27. Review.
PubMed PMID: 22367183.

Schirren J, Trainer S, Eberlein M, Lorch A, Beyer J, Bölükbas S.
The role of residual tumor resection in the management of nonseminomatous germ cell cancer of testicular origin.
Thorac Cardiovasc Surg. 2012 Sep;60(6):405-12. doi: 10.1055/s-0031-1299584. Epub 2012 Mar 1.
PubMed PMID: 22383152.

Selinski S, Lehmann ML, Blaszkewicz M, Ovsiannikov D, Moormann O, Guballa C, Kress A, Truss MC, Gerullis H, Otto T, Barski D, Niegisch G, Albers P, Frees S, Brenner W, Thüroff JW, Angeli-Greaves M, Seidel T, Roth G, Volkert F, Ebbinghaus R, Prager HM, Bolt HM, Falkenstein M, Zimmermann A, Klein T, Reckwitz T, Roemer HC, Hartel M, Weistenhöfer W, Schöps W, Rizvi SA, Aslam M, Bánfi G, Romics I, Ickstadt K, Hengstler JG, Golka K.
Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk.
Arch Toxicol. 2012 Sep;86(9):1369-78. doi: 10.1007/s00204-012-0854-y. Epub 2012 Apr 25.
PubMed PMID: 22532026.

Selinski S, Lehmann ML, Blaszkewicz M, Ovsiannikov D, Moormann O, Guballa C, Kress A, Truss MC, Gerullis H, Otto T, Barski D, Niegisch G, Albers P, Frees S, Brenner W, Thüroff JW, Angeli-Greaves M, Seidel T, Roth G, Volkert F, Ebbinghaus R, Prager HM, Lukas C, Bolt HM, Falkenstein M, Zimmermann A, Klein T, Reckwitz T, Roemer HC, Hartel M, Weistenhöfer W, Schöps W, Rizvi SA, Aslam M, Bánfi G, Romics I, Ickstadt K, Hengstler JG, Golka K.
Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene.
Arch Toxicol. 2012 Feb;86(2):195-203. doi: 10.1007/s00204-011-0747-5. Epub 2011 Sep 3.
PubMed PMID: 21892705.

Sonpavde G, Pond GR, Fougeray R, Choueiri TK, Qu AQ, Vaughn DJ, Niegisch G, Albers P, James ND, Wong YN, Ko YJ, Sridhar SS, Galsky MD, Petrylak DP, Vaishampayan UN, Khan A, Vogelzang NJ, Beer TM, Stadler WM, O'Donnell PH, Sternberg CN, Rosenberg JE, Bellmunt J.
Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials.
Eur Urol. 2012 Nov 26. doi:pii: S0302-2838(12)01417-0. 10.1016/j.eururo.2012.11.042. [Epub ahead of print]
PubMed PMID: 23206856.

Vinarskaja A, Goering W, Ingenwerth M, Schulz WA.
ID4 is frequently downregulated and partially hypermethylated in prostate cancer.
World J Urol. 2012 Jun;30(3):319-25. doi: 10.1007/s00345-011-0750-8. Epub 2011 Sep 1.
PubMed PMID: 21882048.

Winter C, Pfister D, Busch J, Bingöl C, Ranft U, Schrader M, Dieckmann KP, Heidenreich A, Albers P.
Residual tumor size and IGCCCG risk classification predict additional vascular procedures in patients with germ cell tumors and residual tumor resection: a multicenter analysis of the German Testicular Cancer Study Group.
Eur Urol. 2012 Feb;61(2):403-9. doi: 10.1016/j.eururo.2011.10.045. Epub 2011 Nov 7.
PubMed PMID: 22078334.